MHC, KIR and FCR development

Active Definitive Contract Awarded Last action

Contract number
75N93021C00006
Awardee
Awarding agency
Obligated
$6,354,440

Award facts

Opportunity
Contract value 49% obligated
  • $6,354,439.87 Current, with exercised options
  • $12,932,193.87 Potential, with all options
Completion date 78% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 2 offers Negotiated Proposal / Quote
Pricing
Cost No Fee
Place of performance
Madison, WI 53715, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 · EO 14398 -$26,300
Exercise an Option P00012 · The primary purpose of this contract is to discover new NHP MHC class I, MHC class II, KIR, and FCR genes, loci, and alleles; develop genotyping technologies… $1,098,987
Change Order P00011 · EOI::EO:radical transparency about wasteful spending $325,505
Change Order P00010 $349,620
Funding Only Action P00009 $133,943
Exercise an Option P00008 $1,096,909
Funding Only Action P00007 $90,097
Exercise an Option P00006 $1,096,028
Exercise an Option P00004 $1,090,689
Other Administrative Action P00005 $0
Other Administrative Action P00003 · The primary purpose of this contract is to discover new NHP MHC class I, MHC class II, KIR, and FCR genes, loci, and alleles; develop genotyping technologies… $0
Other Administrative Action P00002 · Develop geno typing technologies $0
Other Administrative Action P00001 $0
Original award $1,098,962
Show all 14

About this award

The National Institute of Allergy and Infectious Diseases awarded a $12.93 million definitive contract to University of Wisconsin System, operating through University of Wisconsin–Madison, for discovery and development of nonhuman primate MHC, KIR, and FCR genes and genotyping technologies on June 1, 2021, under a cost-no-fee structure with no set-aside.

The originating Broad Agency Announcement, posted November 4, 2019, solicited proposals to discover and characterize genetic loci, alleles, and haplotypes of monkey MHC and KIR genes; initiate discovery of Fc receptor genes; and develop robust high-throughput genotyping and haplotyping methods to remain freely accessible to the NHP research community. Work is performed in Madison, Wisconsin, with an ultimate completion date of May 31, 2028.

The Baylor College of Medicine and Stichting Biomedical Primate Research Centre participate as subcontractors. Baylor provides whole exome sequencing of nonhuman primate DNA samples and analysis of exome sequence data in variant call file format. BPRC organizes and names MHC, KIR, and FcR sequences; integrates and validates data for inclusion in the Immuno Polymorphism Database; manages and improves the IPD NHP MHC and KIR databases; and loads allele discovery and genotype data into EMBL/NIH databases.

Service Contract Inventory data reflects actual government-invoiced labor across five fiscal years. FY2025 labor footprint was 3.5 FTEs across 7,263 contractor hours, with 24 percent of hours subcontracted. Government-paid hourly rates rose from $19.33 in FY2021 to $56.42 in FY2025.

Subawards

Subcontractor Amount Awarded
Baylor College Of Medicine MHC, KIR AND FCR DEVELOPMENT Dr. Jeffrey Rogers and his team at the Baylor College of Medicine HGSC will be responsible for generating iWES short read and… $75,000
Stichting Biomedical Primate Research Centre MHC, KIR AND FCR DEVELOPMENT Dr. Jeffrey Rogers and his team at the Baylor College of Medicine HGSC will be responsible for generating iWES short read and… $138,672
Baylor College Of Medicine THE PRIMARY PURPOSE OF THIS CONTRACT IS TO DISCOVER NEW NHP MHC CLASS I, MHC CLASS II, KIR, AND FCR GENES, LOCI, AND ALLELES; DEVELOP GENOTYPING TECHNOLOGIES… $75,000
Stichting Biomedical Primate Research Centre THE PRIMARY PURPOSE OF THIS CONTRACT IS TO DISCOVER NEW NHP MHC CLASS I, MHC CLASS II, KIR, AND FCR GENES, LOCI, AND ALLELES; DEVELOP GENOTYPING TECHNOLOGIES… $179,983

Quick answers

Who was awarded contract 75N93021C00006?

75N93021C00006 was awarded to University Of Wisconsin System by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 1, 2021.

How much is contract 75N93021C00006 worth?

The government has obligated $6,354,440 on 75N93021C00006. Its potential value, with all options, is $12,932,194.

Was contract 75N93021C00006 competed?

The extent of competition for 75N93021C00006 was full and open competition. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award